188 related articles for article (PubMed ID: 26366474)
21. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Lee SE; Hwang TS; Choi YL; Han HS; Kim WS; Jang MH; Kim SK; Yang JH
Thyroid; 2016 Jul; 26(7):901-10. PubMed ID: 27184112
[TBL] [Abstract][Full Text] [Related]
22. TERT promoter mutations in thyroid cancer.
Liu R; Xing M
Endocr Relat Cancer; 2016 Mar; 23(3):R143-55. PubMed ID: 26733501
[TBL] [Abstract][Full Text] [Related]
23. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
[TBL] [Abstract][Full Text] [Related]
24. The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.
Helsten T; Elkin S; Arthur E; Tomson BN; Carter J; Kurzrock R
Clin Cancer Res; 2016 Jan; 22(1):259-67. PubMed ID: 26373574
[TBL] [Abstract][Full Text] [Related]
25. Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
Alzahrani AS; Murugan AK; Qasem E; Alswailem M; Al-Hindi H; Shi Y
Thyroid; 2017 Feb; 27(2):189-196. PubMed ID: 27824297
[TBL] [Abstract][Full Text] [Related]
26. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
[TBL] [Abstract][Full Text] [Related]
27. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
[TBL] [Abstract][Full Text] [Related]
28. Molecular Genetics of Thyroid Cancer in Children and Adolescents.
Bauer AJ
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):389-403. PubMed ID: 28476228
[TBL] [Abstract][Full Text] [Related]
29. Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario.
Galuppini F; Vianello F; Censi S; Barollo S; Bertazza L; Carducci S; Colato C; Manso J; Rugge M; Iacobone M; Watutantrige Fernando S; Pennelli G; Mian C
Front Endocrinol (Lausanne); 2019; 10():552. PubMed ID: 31456750
[No Abstract] [Full Text] [Related]
30. Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.
Alzahrani AS; Qasem E; Murugan AK; Al-Hindi HN; AlKhafaji D; Almohanna M; Xing M; Alhomaidah D; AlSwailem M
Thyroid; 2016 Feb; 26(2):235-41. PubMed ID: 26711586
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract][Full Text] [Related]
32. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.
de Sousa MSA; Nunes IN; Christiano YP; Sisdelli L; Cerutti JM
Rev Endocr Metab Disord; 2024 Feb; 25(1):35-51. PubMed ID: 37874477
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Significance of BRAF Gene Analysis in Children and Adolescents with Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Kotanidou EP; Giza S; Tsinopoulou VR; Margaritis K; Papadopoulou A; Sakellari E; Kolanis S; Litou E; Serbis A; Galli-Tsinopoulou A
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980495
[TBL] [Abstract][Full Text] [Related]
34. Molecular Landscape of Pediatric Thyroid Cancer: A Review.
Guleria P; Srinivasan R; Rana C; Agarwal S
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553142
[TBL] [Abstract][Full Text] [Related]
35. Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.
Howard SR; Freeston S; Harrison B; Izatt L; Natu S; Newbold K; Pomplun S; Spoudeas HA; Wilne S; Kurzawinski TR; Gaze MN
Endocr Relat Cancer; 2022 Nov; 29(11):G1-G33. PubMed ID: 35900783
[TBL] [Abstract][Full Text] [Related]
36. Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.
Yang H; Park H; Ryu HJ; Heo J; Kim JS; Oh YL; Choe JH; Kim JH; Kim JS; Jang HW; Kim TH; Kim SW; Chung JH
Endocrinol Metab (Seoul); 2022 Aug; 37(4):652-663. PubMed ID: 35864728
[TBL] [Abstract][Full Text] [Related]
37. The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.
Ricarte-Filho JC; Halada S; O'Neill A; Casado-Medrano V; Laetsch TW; Franco AT; Bauer AJ
Cancer Genet; 2022 Apr; 262-263():57-63. PubMed ID: 35092884
[TBL] [Abstract][Full Text] [Related]
38. Major Oncogenic Drivers and Their Clinicopathological Correlations in Sporadic Childhood Papillary Thyroid Carcinoma in Belarus.
Rogounovitch TI; Mankovskaya SV; Fridman MV; Leonova TA; Kondratovitch VA; Konoplya NE; Yamashita S; Mitsutake N; Saenko VA
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282777
[TBL] [Abstract][Full Text] [Related]
39. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.
Lee YA; Lee H; Im SW; Song YS; Oh DY; Kang HJ; Won JK; Jung KC; Kwon D; Chung EJ; Hah JH; Paeng JC; Kim JH; Choi J; Kim OH; Oh JM; Ahn BC; Wirth LJ; Shin CH; Kim JI; Park YJ
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34237031
[TBL] [Abstract][Full Text] [Related]
40. Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations.
Rangel-Pozzo A; Sisdelli L; Cordioli MIV; Vaisman F; Caria P; Mai S; Cerutti JM
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33120984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
